ORIC FY 2021 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ORICORIC Pharmaceuticals, Inc.

$1B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$79M

Net Income

-$79M

EPS (Diluted)

$-2.07

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$60M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$299M

Total Liabilities

$26M

Stockholders' Equity

$273M

Cash & Equivalents

$226M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$79M	-$74M	-6.3%
Net Income	-$79M	-$74M	-6.8%